SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-23-047626
Filing Date
2023-06-09
Accepted
2023-06-09 08:30:08
Documents
4
Period of Report
2023-06-09

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea180037-6k_nlspharma.htm 6-K 11247
2 NOTICE OF MEETING AND PROXY CARD FOR THE ORDINARY SHAREHOLDERS' MEETING TO BE HE ea180037ex99-1_nlspharma.htm EX-99.1 92948
3 GRAPHIC ex99-1_001.jpg GRAPHIC 777
4 GRAPHIC ex99-1_002.jpg GRAPHIC 720
  Complete submission text file 0001213900-23-047626.txt   107532
Mailing Address THE CIRCLE 6 8058 ZURICH V8 CH-6370
Business Address THE CIRCLE 6 8058 ZURICH V8 CH-6370 41-41-618-80-00
NLS Pharmaceutics Ltd. (Filer) CIK: 0001783036 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39957 | Film No.: 231003942
SIC: 2834 Pharmaceutical Preparations